(2S,4S)-4-(piperazin-1-yl)pyrrolidine-2-methanone derivatives
US7465732B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2006 |
| Grant date | Dec 16, 2008 |
| Priority date | — |
| Expiry date | Dec 7, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds of formula (I),or a pharmaceutically acceptable salt of said compound, or a solvate of said compound or salt, wherein R1, R2, R3, HET, n, Q, X, Y, and Z are as described herein; compositions thereof; and uses thereof including treating Type 2 diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.